Global burden of neoplasms attributable to specific occupational carcinogens over 30 years: a population-based study

Public Health. 2023 Oct:223:145-155. doi: 10.1016/j.puhe.2023.07.032. Epub 2023 Aug 30.

Abstract

Objectives: The study aimed to analyze the global burden of occupational neoplasms from various epidemiological perspectives.

Study design: In this cross-sectional study, secondary analyses were conducted to assess the burden of neoplasms attributable to occupational carcinogens and their distribution characteristics using data from GBD 2019 and the World Bank database.

Methods: Based on the GBD 2019 and the World Bank database, we analyzed the global burden of occupational neoplasms including the age-period-cohort model, decomposition analysis, health inequality analysis, and panel model. All analyses were conducted in R (version 4.0.3) and Joinpoint (version 4.9.1).

Results: The absolute number of neoplasms burden attributable to occupational carcinogens has continued to rise over 30 years. In 2019, occupational neoplasms caused 333,867 [95% uncertainty interval (UI): 263,491 to 404,641] mortalities and 6,964,775 (95% UI: 5,467,884 to 8,580,431) disability-adjusted life years (DALYs) globally. Greenland, Monaco, the Netherlands, and Andorra suffered the highest burden. The burden was higher in countries with a higher sociodemographic index. The age effect was prominent in the elderly, and the 1925 birth cohort had the highest cohort effect. Population growth was the most significant driver of the mortalities (89%) and DALYs (111%) change. Moreover, the proportion of urban population was significantly positively associated with the disease burden, while GDP per capita was negatively correlated with the disease burden.

Conclusions: The burden of occupational neoplasms was unevenly distributed across locations and populations. The need for rational allocation of healthcare resources was urgent.

Keywords: Age-period-cohort; DALYs; Mortality; Neoplasms; Occupational carcinogens.

MeSH terms

  • Aged
  • Carcinogens / toxicity
  • Cross-Sectional Studies
  • Health Status Disparities*
  • Humans
  • Neoplasms* / epidemiology
  • Research

Substances

  • Carcinogens